162 related articles for article (PubMed ID: 35905598)
21. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
Winquist A; Steenland K
Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
[TBL] [Abstract][Full Text] [Related]
22. Derivation of a drinking water equivalent level (DWEL) related to the maximum contaminant level goal for perfluorooctanoic acid (PFOA), a persistent water soluble compound.
Tardiff RG; Carson ML; Sweeney LM; Kirman CR; Tan YM; Andersen M; Bevan C; Gargas ML
Food Chem Toxicol; 2009 Oct; 47(10):2557-89. PubMed ID: 19631249
[TBL] [Abstract][Full Text] [Related]
23. Concentrations of PFOS, PFOA and other perfluorinated alkyl acids in Australian drinking water.
Thompson J; Eaglesham G; Mueller J
Chemosphere; 2011 May; 83(10):1320-5. PubMed ID: 21531441
[TBL] [Abstract][Full Text] [Related]
24. Model-based investigation of the formation, transmission, and health risk of perfluorooctanoic acid, a member of PFASs group, in drinking water distribution systems.
Abhijith GR; Ostfeld A
Water Res; 2021 Oct; 204():117626. PubMed ID: 34517266
[TBL] [Abstract][Full Text] [Related]
25. Concentration, spatial distribution, and health risk assessment of PFASs in serum of teenagers, tap water and soil near a Chinese fluorochemical industrial plant.
Xie LN; Wang XC; Dong XJ; Su LQ; Zhu HJ; Wang C; Zhang DP; Liu FY; Hou SS; Dong B; Shan GQ; Zhang X; Zhu Y
Environ Int; 2021 Jan; 146():106166. PubMed ID: 33068851
[TBL] [Abstract][Full Text] [Related]
26. Critical review on PFOA, kidney cancer, and testicular cancer.
Bartell SM; Vieira VM
J Air Waste Manag Assoc; 2021 Jun; 71(6):663-679. PubMed ID: 33780327
[TBL] [Abstract][Full Text] [Related]
27. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
Barry V; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
[TBL] [Abstract][Full Text] [Related]
28. Assessment of individual-based perfluoroalkly substances exposure by multiple human exposure sources.
Kim DH; Lee JH; Oh JE
J Hazard Mater; 2019 Mar; 365():26-33. PubMed ID: 30399487
[TBL] [Abstract][Full Text] [Related]
29. Quantitative relationships of perfluoroalkyl acids in drinking water associated with serum concentrations above background in adults living near contamination hotspots in Sweden.
Johanson G; Gyllenhammar I; Ekstrand C; Pyko A; Xu Y; Li Y; Norström K; Lilja K; Lindh C; Benskin JP; Georgelis A; Forsell K; Jakobsson K; Glynn A; Vogs C
Environ Res; 2023 Feb; 219():115024. PubMed ID: 36535390
[TBL] [Abstract][Full Text] [Related]
30. Occurrence of perfluorinated compounds in raw water from New Jersey public drinking water systems.
Post GB; Louis JB; Lippincott RL; Procopio NA
Environ Sci Technol; 2013; 47(23):13266-75. PubMed ID: 24187954
[TBL] [Abstract][Full Text] [Related]
31. Perfluorooctanoate exposure and major birth defects.
Stein CR; Savitz DA; Elston B; Thorpe PG; Gilboa SM
Reprod Toxicol; 2014 Aug; 47():15-20. PubMed ID: 24803403
[TBL] [Abstract][Full Text] [Related]
32. Human exposure to perfluoroalkyl substances near a fluorochemical industrial park in China.
Bao J; Liu L; Wang X; Jin YH; Dong GH
Environ Sci Pollut Res Int; 2017 Apr; 24(10):9194-9201. PubMed ID: 28220384
[TBL] [Abstract][Full Text] [Related]
33. Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant.
Watkins DJ; Josson J; Elston B; Bartell SM; Shin HM; Vieira VM; Savitz DA; Fletcher T; Wellenius GA
Environ Health Perspect; 2013 May; 121(5):625-30. PubMed ID: 23482063
[TBL] [Abstract][Full Text] [Related]
34. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community.
Savitz DA; Stein CR; Bartell SM; Elston B; Gong J; Shin HM; Wellenius GA
Epidemiology; 2012 May; 23(3):386-92. PubMed ID: 22370857
[TBL] [Abstract][Full Text] [Related]
35. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project.
Shin HM; Vieira VM; Ryan PB; Steenland K; Bartell SM
Environ Health Perspect; 2011 Dec; 119(12):1760-5. PubMed ID: 21813367
[TBL] [Abstract][Full Text] [Related]
36. Relationship between perfluorooctanoate and perfluorooctane sulfonate blood concentrations in the general population and routine drinking water exposure.
Zhang S; Kang Q; Peng H; Ding M; Zhao F; Zhou Y; Dong Z; Zhang H; Yang M; Tao S; Hu J
Environ Int; 2019 May; 126():54-60. PubMed ID: 30776750
[TBL] [Abstract][Full Text] [Related]
37. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.
Bartell SM; Calafat AM; Lyu C; Kato K; Ryan PB; Steenland K
Environ Health Perspect; 2010 Feb; 118(2):222-8. PubMed ID: 20123620
[TBL] [Abstract][Full Text] [Related]
38. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
Steenland K; Zhao L; Winquist A; Parks C
Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
[TBL] [Abstract][Full Text] [Related]
39. Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid.
Karnes C; Winquist A; Steenland K
Environ Res; 2014 Jan; 128():78-83. PubMed ID: 24299613
[TBL] [Abstract][Full Text] [Related]
40. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.
Frisbee SJ; Shankar A; Knox SS; Steenland K; Savitz DA; Fletcher T; Ducatman AM
Arch Pediatr Adolesc Med; 2010 Sep; 164(9):860-9. PubMed ID: 20819969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
